Title
a. Authorize the Chief Executive Officer for Natividad Medical Center (NMC) or his designee to execute an agreement with Luminex Corporation for preventative maintenance and repair services at NMC for an amount not to exceed $10,000 with an agreement term September 1, 2024 through August 31, 2025.
b. Approve the NMC's Chief Executive Officer's recommendation to accept non-standard indemnification provisions within the agreement.
Report
RECOMMENDATION:
It is recommended the Board of Supervisors:
a. Authorize the Chief Executive Officer for Natividad Medical Center (NMC) or his designee to execute an agreement with Luminex Corporation for preventative maintenance and repair services at NMC for an amount not to exceed $10,000 with an agreement term September 1, 2024 through August 31, 2025.
b. Approve the NMC's Chief Executive Officer's recommendation to accept non-standard indemnification provisions within the agreement.
SUMMARY/DISCUSSION:
Luminex Verigene is an instrument in Microbiology at Natividad Medical Center Laboratory.
It is a qualitative multiplexed in vitro diagnostic test for simultaneous detection and identification of potentially pathogenic gram negative and resistance markers, and gram-positive bacteria which may cause bloodstream infection.
Service contract is needed to continue lab operation without delay and compromising patient care. The service contract includes troubleshooting, calling hotline and changing parts as needed. Having the service contract will save Natividad Medical Center for emergency repair which is very expensive.
OTHER AGENCY INVOLVEMENT:
The Office of County Counsel has reviewed and approved this agreement as to form, and the Auditor-Controller has reviewed and approved as to payment provisions. The agreement has also been reviewed and approved by NMC's Finance Committee and by its Board of Trustees on August 9, 2024.
FINANCING:
The cost for this agreement is $10,000 of which $8,500 is included in the FY 202...
Click here for full text